![Miriam Cruz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Miriam Cruz
Geschäftsführer bei
TURG POIN
Profil
Zurzeit bekleidet Miriam Cruz die Position des Vice President-Clinical Operations bei Turning Point Therapeutics, Inc. Frau Cruz ist außerdem Mitglied der European Society for Medical Oncology und Mitglied der American Society of Clinical Oncology. Zuvor hatte Frau Cruz die Position des Vice President-Clinical Operations bei Viracta Therapeutics, Inc. inne. Frau Cruz erwarb einen Bachelor-Abschluss am City College of New York.
Aktive Positionen von Miriam Cruz
| Unternehmen | Position | Beginn |
|---|---|---|
| TURG POIN | Geschäftsführer | 01.06.2018 |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Corporate Officer/Principal | - |
European Society for Medical Oncology
 European Society for Medical Oncology Medical/Nursing ServicesHealth Services Operates as a medical oncology society | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Miriam Cruz
| Unternehmen | Position | Ende |
|---|---|---|
Viracta Subsidiary, Inc.
 Viracta Subsidiary, Inc. BiotechnologyHealth Technology Develops proprietary viral gene activation therapy to address cancers associated with the epstein-barr virus | Geschäftsführer | 01.01.2018 |
Ausbildung von Miriam Cruz
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
81
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage structure-based drug design company for discovery and development of precision medicines for cancer and other diseases | Health Technology |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Health Services |
European Society for Medical Oncology
European Society for Medical Oncology Medical/Nursing ServicesHealth Services Operates as a medical oncology society | Health Services |
The City College of New York
 The City College of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Viracta Subsidiary, Inc.
Viracta Subsidiary, Inc. BiotechnologyHealth Technology Develops proprietary viral gene activation therapy to address cancers associated with the epstein-barr virus | Health Technology |
